Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 69
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tolfine 40 mg/ml V/NRP/08/1583 Vetoquinol S.A., Francija QM01AG02 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tolfenamic acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z o.o., Polija;Vetoquinol S.A., Francija
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1583-01 40 mg/ml 1 Flakons, 100 ml -
V/NRP/08/1583-02 40 mg/ml 1 Flakons, 50 ml -
V/NRP/08/1583-03 40 mg/ml 1 Flakons, 250 ml -
Bovilis Rotavec Corona - V/MRP/08/0002 Intervet International B.V., Nīderlande QI02AL01 cattle Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Bovine coronavirus, strain Mebus, Inactivated, Bovine rotavirus, strain UK-Compton, Inactivated, E. coli F5 (K99) adhesin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 09-Jul-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/0002-01 10 Stikla flakons, 2 ml -
V/MRP/08/0002-02 1 Stikla flakons, 10 ml -
V/MRP/08/0002-03 1 Stikla flakons, 40 ml -
V/MRP/08/0002-04 1 Stikla flakons, 100 ml -
V/MRP/08/0002-05 1 PET flakons, 10 ml -
V/MRP/08/0002-06 1 PET flakons, 40 ml -
V/MRP/08/0002-07 1 PET flakons, 100 ml -
Duplocillin LA - V/NRP/96/0457 Intervet International B.V., Nīderlande QJ01CR50 cattle; pigs; sheep; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Benzathine benzylpenicillin, Procaine benzylpenicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Aprilia Animal Health S.r.l., Itālija
Date of authorisation/renewal: 17-Nov-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0457-01 1 Stikla flakons, 100 ml -
V/NRP/96/0457-02 1 Stikla flakons, 250 ml -
V/NRP/96/0457-03 1 PET flakons, 100 ml -
V/NRP/96/0457-04 1 PET flakons, 250 ml -
Metrobactin vet 250 mg V/DCP/15/0054 Dechra Regulatory B.V., Nīderlande QP51AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 21-Dec-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0054-01 250 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-02 250 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-03 250 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-04 250 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-05 250 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-06 250 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-07 250 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-08 250 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-09 250 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-10 250 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-11 250 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-12 250 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-13 250 mg 10 Kastīte ar blisteri, 10 tablete -
V/DCP/15/0054-14 250 mg 10 Kastīte ar blisteri, 100 tablete -
Metrobactin vet 500 mg V/DCP/15/0055 Dechra Regulatory B.V., Nīderlande QP51AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 21-Dec-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0055-01 500 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-02 500 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-03 500 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-04 500 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-05 500 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-06 500 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-07 500 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-08 500 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-09 500 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-10 500 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-11 500 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-12 500 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-13 500 mg 10 Kastīte ar blisteri, 10 tablete -
V/DCP/15/0055-14 500 mg 10 Kastīte ar blisteri, 100 tablete -
Canizol vet 200 mg V/DCP/14/0052 Dechra Regulatory B.V., Nīderlande QJ02AB02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Ketoconazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0052-01 200 mg 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-02 200 mg 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-03 200 mg 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-04 200 mg 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-05 200 mg 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-06 200 mg 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-07 200 mg 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-08 200 mg 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-09 200 mg 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-10 200 mg 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Canizol vet 400 mg V/DCP/14/0053 Dechra Regulatory B.V., Nīderlande QJ02AB02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Ketoconazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0053-01 400 mg 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-02 400 mg 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-03 400 mg 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-04 400 mg 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-05 400 mg 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-06 400 mg 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-07 400 mg 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-08 400 mg 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-09 400 mg 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-10 400 mg 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Pyrocam 15 mg/ml V/DCP/23/0049 Huvepharma NV, Beļģija QM01AC06 pigs Vairāk

Medicinal product information

Pharmaceutical form: Oral suspension
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet JSC, Bulgārija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Sep-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0049-01 15 mg/ml 1 ABPE pudele, 125 ml -
V/DCP/23/0049-02 15 mg/ml 1 ABPE pudele, 250 ml -
V/DCP/23/0049-03 15 mg/ml 1 ABPE pudele, 1000 ml -
Cevac Transmune - V/MRP/13/0036 Ceva Sante Animale., Francija QI01AD09 chickens

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Avian infectious bursal disease virus Winterfield 2512, G-61 strain
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 09-Dec-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 200421_LI (20-Apr-2021)
Labelling text: [DOC] 200421_M (20-Apr-2021)
Summary of product characteristics: [DOCX] 200421_ZA (20-Apr-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0036-01 20 Stikla flakons, 2000 deva -
V/MRP/13/0036-02 20 Stikla flakons, 2500 deva -
V/MRP/13/0036-03 20 Stikla flakons, 4000 deva -
V/MRP/13/0036-04 20 Stikla flakons, 5000 deva -
V/MRP/13/0036-05 20 Stikla flakons, 8000 deva -
V/MRP/13/0036-06 1 Stikla flakons, 2000 deva -
V/MRP/13/0036-07 1 Stikla flakons, 2500 deva -
V/MRP/13/0036-08 1 Stikla flakons, 4000 deva -
V/MRP/13/0036-09 1 Stikla flakons, 5000 deva -
V/MRP/13/0036-10 1 Stikla flakons, 8000 deva -
Api-Bioxal 886 mg/g V/MRP/21/0019 Chemicals Laif S.p.A., Itālija QP53AG03 honey bees Vairāk

Medicinal product information

Pharmaceutical form: Powder for in-hive use
International name (active substance): Oxalic acid dihydrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chemifarma S.p.A., Itālija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 230321M+LI (23-Mar-2021)
Labelling text: [DOCX] 230321M+LI (23-Mar-2021)
Summary of product characteristics: [DOCX] 230321ZA (23-Mar-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0019-01 886 mg/g 1 iepakojums, 35 g -
V/MRP/21/0019-02 886 mg/g 1 iepakojums, 175 g -
V/MRP/21/0019-03 886 mg/g 1 iepakojums, 350 g -
Elivex 5 mg/ml V/DCP/18/0006 Industrial Veterinaria, S.A., Spānija QP54AA04 cattle; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: Pour-on solution
International name (active substance): Eprinomectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0006-01 1 ABPE pudele, 1 l -
V/DCP/18/0006-02 1 ABPE pudele, 2,5 l -
V/DCP/18/0006-03 1 ABPE pudele, 5 l -
Milbeguard Duo 2,5 mg / 25 mg mg V/DCP/23/0051 Ceva Sante Animale', Francija QP54AB51 small dogs; puppies Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0051-02 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-03 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-04 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-05 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-06 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-07 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 12,5 mg / 125 mg mg V/DCP/23/0052 Ceva Sante Animale', Francija QP54AB51 Dogs > 2.5-5 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0052-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 25 mg / 250 mg mg V/DCP/23/0053 Ceva Sante Animale', Francija QP54AB51 large dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0053-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 4 mg/10 mg mg V/DCP/23/0054 Ceva Sante Animale', Francija QP54AB51 small cats; kittens Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0054-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 16 mg / 40 mg mg V/DCP/23/0055 Ceva Sante Animale', Francija QP54AB51 cats weighing at least 2 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0055-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Reuflogin 50 mg/ml V/NRP/02/1493 Fatro S.p.A., Itālija QM01AB05 horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Diclofenac sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1493-01 50 mg/ml 1 Stikla flakons, 50 ml -
Fypryst Combo 50mg/60mg - V/DCP/14/0014 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 ferrets; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil, S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0014-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0014-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0014-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0014-04 10 Polipropilēna pipete, 1 deva -
Fypryst Combo 67mg/60,3mg - V/DCP/14/0015 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil, S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0015-01 1 Pipete, 1 deva -
V/DCP/14/0015-02 3 Pipete, 1 deva -
V/DCP/14/0015-03 6 Pipete, 1 deva -
V/DCP/14/0015-04 10 Pipete, 1 deva -
Fypryst Combo 134mg/120,6mg - V/DCP/14/0011 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0011-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0011-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0011-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0011-04 10 Polipropilēna pipete, 1 deva -

3082 records

© Food and veterinary service · 2026 Cookies policy